mifepristone (Mifeprex, RU-486, Mifegyne)

From Aaushi
Jump to navigation Jump to search

Introduction

Controversial abortion pill. Available 11/2000;

Indications

  • termination of pregnancy of < 70 day duration

Dosage

Adverse effects

Mechanism of action

More general terms

References

  1. Prescriber's Letter 7(10):56 2000
  2. 2.0 2.1 FDA Medwatch http://www.fda.gov/medwatch/safety/2005/safety05.htm#Mifeprex http://www.fda.gov/medwatch/safety/2006/safety06.htm#Mifeprex
  3. FDA Drug Safety. March 30, 2016 Mifeprex (mifepristone) Information http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111323.htm
  4. 4.0 4.1 4.2 Greene MF, Drazen JM A New Label for Mifepristone. N Engl J Med 2016; 374:2281-2282. June 9, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27276566 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1604462
  5. 5.0 5.1 Schreiber CA, Creinin MD, Atrio J et al. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med 2018 Jun 7; 378:2161. June 7, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29874535 https://www.nejm.org/doi/10.1056/NEJMoa1715726
    Westhoff CL. A better medical regimen for the management of miscarriage. N Engl J Med 2018 Jun 7; 378:2232. June 7, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29874544 https://www.nejm.org/doi/10.1056/NEJMe1804945
  6. 6.0 6.1 US Food & Drug Administration. Jan 24, 2023 Information about Mifepristone for Medical Termination of Pregnancy Through Ten Weeks Gestation. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation

Database